- Market Research
- Stocks Research
- ETF Research
- Mutual Funds Research
- Options Research
- Bonds & Fixed Income Research
View our ETF quotes and sample our research offering.
Try our powerful tools to help compare investments and get ideas.
Find out about our industry leading research providers.
Amplify Weight Loss Drug & Treatment ETF THNR:NYSE Arca
| Last Price | Today's Change | Today's Volume |  |  | |||
|---|---|---|---|---|---|---|---|
| $26.04 | -0.2115 (-0.81%) | 3,480 Above Avg. | |||||
| As of 10:07 am ET 10/22/2024 | |||||||
Fund Performance
Fund Strategy
The investment seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index. The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Additional Information
Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite similar to mutual funds. One unique ETF feature is transparency, allowing investors to see the underlying portfolio securities on a daily basis.
| Details as of 10:07 am ET 10/22/2024 | |
|---|---|
| Today's Open | $26.10 |
| Previous Close | $26.2515 |
| Day's Range | $26.04 - $26.10 |
| 52 Week Range | $24.92 - $28.1938 |
| Closing NAV 10/21/2024 | $26.20 |
|---|---|
| Premium/Discount 10/21/2024 | 0.19% |
| Avg. Volume (10 Day) | 2,844 |
| Put/Call Ratio (1 Day) | -- |
| Put/Call Ratio (30 Day) | -- |
| Fund Profile | |||
| Fund Type | Exchange Traded Fund | Total Assets | $4.8M |
|---|---|---|---|
| Inception | 05/20/2024 | Gross Expense Ratio | 0.59% |
| Total Holdings | 32 | Net Expense Ratio | 0.59% |
Leveraged Exchange Traded ProductsLeveraged ETPs (exchange-traded products) typically use derivatives to attempt to multiply the returns of the underlying index each day. These products invest their portfolios much differently than other ETPs. They have the propensity to be more volatile and are inherently riskier than their non-leveraged counterparts. It is important to remember that these securities are generally designed for daily use only, and are generally not intended to be held overnight, because their returns over longer periods generally do not match the ETP’s multiple of the underlying index over those periods. These funds are not appropriate for most investors. Leveraged Closed-end FundsFunds that borrow money to purchase more assets in this way will generally move up more than the market when the market rises and move down farther than the market when the market falls. Bond funds that use leverage have the potential to increase the amount of income that they pay out, but at the cost of larger drops in value during a falling market. Leverage inherently increases the risk in a portfolio. 0824-U08J | No | Portfolio Turnover | -- |
| For ETFs, this refers to the number of times the fund is long or short the index to explain its leverage factor. For example, -300 means that the ETF is short 3 times the index. | -- | ESG FundEnvironmental, Social, and Governance (ESG) is the industry term Schwab has chosen to use as an umbrella term to describe various investing approaches that consider not only traditional measures of risk and return, but environmental, social, and corporate governance (ESG) factors as well. Schwab uses ESG to broadly encompass ESG investing , but also investing approaches described as "values-based investing," "impact investing," "sustainable investing," and other approaches. An ESG product may apply ESG factors to its investment or governance processes in many different ways. A product that employs ESG strategies may choose to focus on one or more ESG factors, though an ESG product may also include securities that don't fit any ESG category. The information displayed utilizes the Morningstar "Sustainable Investment - Overall" datapoint. Click here to learn more about ESG at Schwab. 0824-U08J | No |
| Fund Company | Amplify ETFs | Active Semi-transparent Active Semi-transparent ETFsActive semi-transparent ETFs reveal full portfolio holdings only on a monthly or quarterly basis, not daily like traditional ETFs. There are different degrees of transparency as some firms will not disclose any daily holdings and others will reveal holdings daily, but shield certain positions and weights. Certain active semi-transparent ETFs may not be available for purchase or custody at Schwab. 0824-U08J | No |
| Morningstar Category Health portfolios focus on the medical and health-care industries. Most invest in a range of companies, buying everything from pharmaceutical and medical-device makers to HMOs, hospitals, and nursing homes. A few portfolios concentrate on just one industry segment, such as service providers or biotechnology firms. | Health | Buffer ETFsBuffer ETFs provide investors with the opportunity to participate in the upside of an asset’s risk while giving investors some level of downside protection during a stated outcome period (typically one year). An upside return cap represents the maximum percentage of return an investor can achieve, and an investor will not participate in any excess returns above the cap. Buffer ETFs may limit an investor’s losses up to an ETF’s stated buffer limit; however, in the event of a decline in the underlying investments in excess of the buffer limit, the investor can experience those losses. Return cap and downside buffer levels for a Buffer ETF are established at the beginning of each outcome period and will likely differ from the prior outcome period. Buffer ETFs invest primarily in FLexible EXchange (“FLEX”) options to employ a structured or defined outcome strategy. 0824-U08J | No |
Inverse ETPInverse ETPs (exchange-traded products) typically use derivatives to attempt to move in the opposite direction of the underlying index by a certain multiple each day. They generally have either a negative number like –1x or –2x or a term like “short” or “inverse” in their names. These products invest their portfolios much differently than other ETPs. They have the propensity to be more volatile and are inherently riskier than their non-inverse counterparts. It is important to remember that these securities are designed for daily use only, and are not intended to be held overnight, because their returns over longer periods generally do not match the ETP’s negative multiple of the underlying index over longer periods. These funds are not appropriate for most investors. 0824-U08J | No | ||
| Annualized Trend 1,5,10 Year | Annualized Returns | ||||
|---|---|---|---|---|---|
| Description | 1 Year | 5 Year | 10 Year | Inception 05/2024 | |
| THNR Market Price | -- | -- | -- | +6.3% | |
| THNR NAV | -- | -- | -- | +6.1% | |
| HealthMorningstar Category | +21.4% | +9.4% | +8.6% | -- | |
| MSCI ACWI NR USDBroad-Based Index | +31.8% | +12.2% | +9.4% | +6.6% | |
Datasource: Morningstar All performance periods are based on closing daily prices. | |||||
| View Performance | |||||
Top 10 Holdings as of 10/18/2024
Symbol | Description | % of Net Assets | Sector | YTD Chg. % | |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co |
| Health Care | +55.4% | |
| NVO | Novo Nordisk AS ADR |
| Health Care | +13.4% | |
| -- | Roche Holding AG |
| Health Care | -- | |
| PFE | Pfizer Inc |
| Health Care | +0.5% | |
| AZN | AstraZeneca PLC ADR |
| Health Care | +15.0% | |
| TMO | Thermo Fisher Scientific Inc |
| Health Care | +12.2% | |
| AMGN | Amgen Inc |
| Health Care | +10.0% | |
| MRK | Merck & Co Inc |
| Health Care | -2.5% | |
| -- | Chugai Pharmaceutical Co Ltd |
| Health Care | -- | |
| -- | FUJIFILM Holdings Corp |
| Health Care | -- | |
| % of portfolio in top 10 holdings: 68.84% | |||||
| View Portfolio, All Holdings | |||||
Narrow your ETF choices
The new ETF Select List® — see our experts' top picks from a multitude of Schwab and third-party ETFs.
Watchlist
ETF Resource Center
Why are ETFs so popular?
Exchange traded funds have gained the favor of investors because of their low expense ratios, tax efficiency, diversification, trading flexibility and liquidity. They offer a lower relative cost alternative to other vehicles such as stocks and many mutual funds.
Where are ETFs traded?
What are the associated risks?
Do ETFs come with a prospectus?
A sector fund focuses on companies in a specific sector and may involve a greater degree of risk than an investment in funds with broader diversification.
- Investors in ETFs should consider carefully information contained in the prospectus, including investment objectives, risks, charges and expenses. You can view, download, and print a prospectus by selecting the "View Prospectus" link at the top of the page. If there are remaining questions, please call 1-800-435-4000. Please read the prospectus carefully before investing.
- Unlike mutual funds, shares of ETFs are not individually redeemable directly with the ETF. Shares are bought and sold at market price, which may be higher or lower than the net asset value (NAV).
- Data Source Identification
- Schwab's Financial and Other Relationships with certain ETFs
- Morningstar proprietary ratings reflect historical risk-adjusted performance. For each fund with at least a 3-year history, Morningstar calculates a Morningstar Rating™ based on a Morningstar risk-adjusted return measure that accounts for variation in a fund’s monthly performance (including the effects of sales charges, loads and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. (Each share class is counted as a fraction of 1 fund within this scale and rated separately, which may cause slight variations in the distribution percentages). The top 10% of the funds in an investment category receive 5 stars, 22.5% receive 4 stars, 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star.